Assessing the Costs and Benefits of an Oral Vaccine for Raccoon Rabies: A Possible Model

Any cost-benefit analysis of the use of an oral vaccine to control raccoon rabies should include calculating both costs and benefits in terms of $/unit area. Further, cost savings must be adjusted to match the stages of an epizootic: pre-epizootic, epizootic, and post-epizootic. A generic model, whi...

Full description

Bibliographic Details
Main Author: Martin I. Meltzer
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 1996-10-01
Series:Emerging Infectious Diseases
Subjects:
Online Access:https://wwwnc.cdc.gov/eid/article/2/4/96-0411_article
_version_ 1811287050343677952
author Martin I. Meltzer
author_facet Martin I. Meltzer
author_sort Martin I. Meltzer
collection DOAJ
description Any cost-benefit analysis of the use of an oral vaccine to control raccoon rabies should include calculating both costs and benefits in terms of $/unit area. Further, cost savings must be adjusted to match the stages of an epizootic: pre-epizootic, epizootic, and post-epizootic. A generic model, which can be adapted to different sites, illustrates the use of threshold analysis to link distribution costs, cost savings, bait density, and vaccine price. Initial results indicate the need to lower the cost of the vaccine, continue research to determine optimal bait densities, and examine distribution plans that do not require continued protection of areas in which raccoon rabies was eliminated through previous vaccination programs.
first_indexed 2024-04-13T03:11:12Z
format Article
id doaj.art-5449e361586c4598b389e79ccb045044
institution Directory Open Access Journal
issn 1080-6040
1080-6059
language English
last_indexed 2024-04-13T03:11:12Z
publishDate 1996-10-01
publisher Centers for Disease Control and Prevention
record_format Article
series Emerging Infectious Diseases
spelling doaj.art-5449e361586c4598b389e79ccb0450442022-12-22T03:05:03ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60591996-10-012434334910.3201/eid0204.960411Assessing the Costs and Benefits of an Oral Vaccine for Raccoon Rabies: A Possible ModelMartin I. MeltzerAny cost-benefit analysis of the use of an oral vaccine to control raccoon rabies should include calculating both costs and benefits in terms of $/unit area. Further, cost savings must be adjusted to match the stages of an epizootic: pre-epizootic, epizootic, and post-epizootic. A generic model, which can be adapted to different sites, illustrates the use of threshold analysis to link distribution costs, cost savings, bait density, and vaccine price. Initial results indicate the need to lower the cost of the vaccine, continue research to determine optimal bait densities, and examine distribution plans that do not require continued protection of areas in which raccoon rabies was eliminated through previous vaccination programs.https://wwwnc.cdc.gov/eid/article/2/4/96-0411_articleUnited States
spellingShingle Martin I. Meltzer
Assessing the Costs and Benefits of an Oral Vaccine for Raccoon Rabies: A Possible Model
Emerging Infectious Diseases
United States
title Assessing the Costs and Benefits of an Oral Vaccine for Raccoon Rabies: A Possible Model
title_full Assessing the Costs and Benefits of an Oral Vaccine for Raccoon Rabies: A Possible Model
title_fullStr Assessing the Costs and Benefits of an Oral Vaccine for Raccoon Rabies: A Possible Model
title_full_unstemmed Assessing the Costs and Benefits of an Oral Vaccine for Raccoon Rabies: A Possible Model
title_short Assessing the Costs and Benefits of an Oral Vaccine for Raccoon Rabies: A Possible Model
title_sort assessing the costs and benefits of an oral vaccine for raccoon rabies a possible model
topic United States
url https://wwwnc.cdc.gov/eid/article/2/4/96-0411_article
work_keys_str_mv AT martinimeltzer assessingthecostsandbenefitsofanoralvaccineforraccoonrabiesapossiblemodel